Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Bioxyne.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
News
ASX Lunch Wrap: Jumbo, Inghams, Accent sink, ending ASX winning streak
News
ASX Lunch Wrap: Shares on track for 10th straight gain, First Lithium soars, Megaport sinks 20pc
Health & Biotech
THC gummies are getting popular, here are 3 ASX cannabis companies offering the product
Stockhead TV
Break it Down: Bioxyne goes gummy gaga in Australian first
News
Top 10 at 11: Gold, gas, money and THC gummies are today’s happy news
Health & Biotech
Bioxyne sweetens the pot as Australia’s first manufacturer of pharmaceutical cannabis gummies
News
Market Highlights: Wall Street halts winning streak, but Netflix and gold price hit record highs
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: ASX down 0.5pc, FMG down 10.2pc, and it looks like Rex is down for the count
Health & Biotech
ASX wellness stocks offering calm and anxiety relief – Part 1
Health & Biotech
Bioxyne highlights risks of unregulated psychedelic use
Health & Biotech
So mushroom for growth: Bioxyne subsidiary inks psilocybin deal with Swiss pharma company
News
Closing Bell: Oil weighs on flat ASX; Errawarra jumps 65pc on scent of fresh lithium
Health & Biotech
